Hantz Financial Services Inc. Grows Position in Danaher Co. (NYSE:DHR)

Hantz Financial Services Inc. raised its holdings in Danaher Co. (NYSE:DHR) by 37.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,210 shares of the conglomerate’s stock after purchasing an additional 4,710 shares during the period. Hantz Financial Services Inc.’s holdings in Danaher were worth $3,951,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Decker Retirement Planning Inc. bought a new stake in Danaher during the 4th quarter valued at $31,000. Teachers Insurance & Annuity Association of America purchased a new position in shares of Danaher in the third quarter valued at $39,000. MidAtlantic Capital Management Inc. purchased a new stake in Danaher during the 3rd quarter worth about $40,000. FSA Wealth Management LLC bought a new position in Danaher in the 3rd quarter worth about $50,000. Finally, Darwin Wealth Management LLC purchased a new position in Danaher during the 3rd quarter valued at about $55,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.3 %

NYSE:DHR opened at $223.16 on Friday. Danaher Co. has a one year low of $221.34 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company’s 50-day simple moving average is $235.89 and its 200 day simple moving average is $253.45. The firm has a market capitalization of $161.19 billion, a P/E ratio of 42.59, a PEG ratio of 4.43 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same quarter in the prior year, the firm earned $2.09 earnings per share. As a group, analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is 20.61%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of analyst reports. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Stifel Nicolaus boosted their price target on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. lowered their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research report on Friday, December 13th. Finally, Barclays lowered their price target on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday. Six research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.